Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Monash IVF Group Ltd ( (AU:MVF) ) has issued an update.
Monash IVF Group Ltd announced the resignation of CEO and Managing Director Michael Knaap, who has been with the company since 2019, leading it through significant growth and transformation. Malik Jainudeen, the current Chief Financial Officer and Company Secretary, has been appointed as Acting CEO, bringing over a decade of experience with the company and a strong background in financial and healthcare sectors.
The most recent analyst rating on (AU:MVF) stock is a Buy with a A$1.55 price target. To see the full list of analyst forecasts on Monash IVF Group Ltd stock, see the AU:MVF Stock Forecast page.
More about Monash IVF Group Ltd
Monash IVF Group Ltd operates in the healthcare industry, specializing in reproductive services and fertility treatments. The company focuses on providing advanced medical solutions to assist individuals and couples in achieving successful pregnancies.
Average Trading Volume: 3,697,136
Technical Sentiment Signal: Sell
Current Market Cap: A$212.4M
For a thorough assessment of MVF stock, go to TipRanks’ Stock Analysis page.